Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and PDE 5-inhibitors, processes for preparing them and their use in the treatment of pulmonary hypertension.

Abstract: In DVB/MPEG transport streams, the PID specifies the assignment of the packets to the different elementary streams. For reproduction of the elementary streams, for instance by a set-top box with outputting via the screen of a television set, the packets of the desired program have to be selected from the transport stream by means of the PIDs using the demultiplexer. This requires in each case the evaluation of the Program Association Table and Program Map Table, and also that the PIDs of the elementary streams to be reproduced be known to the demultiplexer in the set-top box. If the set-top box has a digital interface via which parts of the transport data stream can be stored and reproduced later or via which an arbitrary transport data stream can be fed to the set-top box, the demultiplexer must firstly be reprogrammed with the PIDs.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and pegsunercept, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and etiprednol, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and TACE (TNF alpha converting enzyme) inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: A pharmaceutical composition containing an anticholinergic of formula 1 wherein X? is an anion; a formoterol salt selected from formoterol fumarate and formoterol hemifumarate, or a hydrate, solvate, enantiomer, or mixtures of enantiomers thereof; and a steroid selected from ciclesonide, budesonide, and mometasone furoate, or a solvate or hydrate thereof.

Abstract: A pharmaceutical composition comprising an anticholinergic of formula 1 wherein X? is an anion; salmeterol xinafoate, or a hydrate, solvate, enantiomer, or mixtures of enantiomers thereof; and a steroid selected from ciclesonide, budesonide, and mometasone furoate, or a solvate or hydrate thereof.

Abstract: MPEG2 data streams contain data packets for a set of programs and time stamps for data synchronization purposes. An MPEG2 transport stream is assembled of fixed-length transport packets. The received transport packets of at least one specific program of this set of programs can be stored using for example a DVD Streamer recorder or DVD-RAM recorder. For the real-time playback of recorded specific program data packets each packet needs a separate time stamp. For that reason a timestamp is to be captured for each data packet at recording time. However, capturing of timestamps from a transport stream is a very time consuming action in software implementation processing. Therefore transport stream timestamps are captured for every Nth packet only and the missing timestamps are calculated. Thereby software-processing time is saved for generating the timestamps required for real-time bitstream recording.

Abstract: The present invention relates to novel pharmaceutical compositions based on steroids and salts of an anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: Fluorenecarboxylic acid esters of general formula 1 wherein X? and the groups A, R, R1, R2, R3, R3?, R4, and R4? have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof as medicaments.

Abstract: The present invention relates to new compounds of general formula 1 wherein X? and the groups A, B, R, R1, R2, R3, R3?, R4, R4?, Rx and Rx? may have the meanings given in the claims and in the specification, processes for preparing them and their use as pharmaceutical compositions.

Abstract: A pharmaceutical formulation comprising: (a) at least one anticholinergic of formula 1 wherein X? is an anion with a single negative charge; (b) at least one corticosteroid (2); and (c) at least one betamimetic (3), and the enantiomers, mixtures of the enantiomers, racemates, solvates, hydrates, or physiologically acceptable acid addition salts thereof, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The invention relates to the use of dopamine receptor agonists for preparing a pharmaceutical composition for the reduction of excessive food intake.

Abstract: The invention relates to the use of anticholinergics for preparing a pharmaceutical composition for the prevention and treatment of proliferative processes.

Abstract: The invention relates to compounds of general formula 1 wherein n, A, B, D, L, R1, R2, R3 and R4 may have the meanings given in the claims and in the specification, processes for preparing them, and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.

Abstract: The present invention relates to new medicament combinations which contain in addition to one or more, preferably one, compound of general formula 1 wherein the groups R1, R2 and R3 may have the meanings given in the claims and in the specification, at least one other active substance 2, processes for preparing them and their use as pharmaceutical compositions.

Abstract: The present invention relates to novel drug compositions based on compounds of general formula 1 wherein X? and the groups A, B, R, R1, R2, R3, R3?, R4 and R4? may have the meanings given in the claims and in the specification and EGFR kinase inhibitors, processes for preparing them and their use in the treatment of respiratory complaints.

Abstract: The present invention relates to new anticholinergics of general formula 1 wherein A, X?, and the groups R1, R2, R3, R4, R5, R6 and R7 may have the meanings given in the claims and in the specification, processes for preparing them and their use as pharmaceutical compositions.

Abstract: The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1 and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.